Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Leukemia Research|March 7, 2003
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatmentApostolia Maria Tsimberidou, Tracey Waddelow, Hagop M Kantarjian, et al.
Cancer|May 13, 2004
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndromeApostolia-Maria Tsimberidou, James L Murray, Susan O'Brien, et al.
American Journal of Hematology|May 14, 2009
Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experienceSushma Vemulapalli, Lakshmi Chintala, Apostolia-Maria Tsimberidou, et al.
Cancer|August 7, 2008
The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromesApostolia Maria Tsimberidou, Elihu Estey, Sijin Wen, et al.
Haematologica|December 30, 2006
Anaplastic large cell lymphoma with involvement of the pancreas presenting as panniculitis in a patient with a history of acute myeloid leukemia--case report and review of the literatureBilal Ahmed, Elihu Estey, John Manning, et al.
JCO Precision Oncology|January 26, 2023
First-in-Human Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients With Advanced Solid TumorsApostolia Maria Tsimberidou, Henry Hiep Vo, Jennifer Beck, et al.
British Journal of Haematology|January 18, 2006
The role of gemtuzumab ozogamicin in acute leukaemia therapyApostolia-Maria Tsimberidou, Francis J Giles, Elihu Estey, et al.
British Journal of Cancer|May 12, 2023
Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumorsApostolia Maria Tsimberidou, Claire F Verschraegen, Robert Wesolowski, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2009
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumorsApostolia Maria Tsimberidou, Michelle A Rudek, David Hong, et al.
Leukemia Research|May 4, 2004
Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literatureApostolia-Maria Tsimberidou, Jorge Medina, Jorge Cortes, et al.
Pageof 10